The trial is from cJASN, so we do have a visual abstract from Pablo Garcia, in the cJASN style
And Omar as well created another visual abstract, in his own inimitable style
This week, we will discuss the 2025 KDIGO IgAN guidelines. which the shift from supportive care to structured, evidence-based therapy
This week, we will discuss an old dilemma in nephrology. To restrict or supplement the proteins? Premise: advanced CKD and dialysis.
This week, we will discuss the use of creating chimeras to induce immune tolerance and its potential to decrease or eliminate the need for immunosuppression in kidney transplant recipients.
The trial is from cJASN, so we do have a visual abstract from Pablo Garcia, in the cJASN style
And Omar as well created another visual abstract, in his own inimitable style